Simulations Plus Inc.

Simulations Plus Inc.

SLP

Get informed when a big investor buys or sells

+ Follow
Market Cap$371.93M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Simulations Plus Inc.Simulations Plus Inc.44.9-6%4.6-
$18.50

Target Price by Analysts

0.4% upsideSimulations Plus Target Price DetailsTarget Price
$23.33

Current Fair Value

26.7% upside

Undervalued by 26.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$371.93 Million
Enterprise Value$342.64 Million
Dividend Yield$- (-)
Earnings per Share$-3.22
Beta1.33
Outstanding Shares20,170,000

Return

Return on Equity5.83%ROE
Return on Assets5.30%
Return on Invested Capital-46.36%

Valuation & Multiples

P/E Ratio44.88P/E Ratio
PEG-42.61PEG
Price to Sales4.61Price to Sales
Price to Book Ratio3.07Price to Book Ratio
Enterprise Value to Revenue4.18
Enterprise Value to EBIT-5.3
Enterprise Value to Net Income42
Total Debt to Enterprise0.02
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 13, 2026
EPS Estimate
$0.23
Average shareholder expectation
Revenue Estimate
$20.92 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$0.11
Average shareholder expectation
Revenue Estimate
$17.59 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 6.60%
Total Calls14,400 92.80%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %79.57% 0.51%
Total Invested$292.56M 53.08%
Investors Holding170 9.00%

ESG Score

No data

About Simulations Plus Inc.

108 employees

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...